IP Verse

Azurity Pharmaceuticals, Inc. vs EXELIXIS, INC.

The detailed information for PTAB case with proceeding number IPR2025-00210 filed by Azurity Pharmaceuticals, Inc. against EXELIXIS, INC. on Nov 18, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2025-00210
Filing Date
Nov 18, 2024
Petitioner
Azurity Pharmaceuticals, Inc.
Respondent
EXELIXIS, INC.
Status
Institution Denied
Respondent Application Number
17170275
Respondent Tech Center
1600
Respondent Patent Number
11298349
Institution Decision Date
Jun 4, 2025
Termination Date
Jun 4, 2025

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Institution Decision: Deny

Jun 4, 2025PAPERBOARD

Patent Owner's Update to Mandatory Notices

May 1, 2025PAPERPATENT OWNER

Patent Owner's Update to Mandatory Notices

Apr 8, 2025PAPERPATENT OWNER

Patent Owner's Preliminary Response

Mar 11, 2025PAPERPATENT OWNER

Trial Tr. Vol. 1, Oct. 23, 2023

Mar 11, 2025EXHIBITPATENT OWNER

Trial Tr. Vol. 2, Oct. 24, 2023

Mar 11, 2025EXHIBITPATENT OWNER

Trial Tr. Vol. 3, Oct. 25, 2023

Mar 11, 2025EXHIBITPATENT OWNER

Trial Tr. Vol 4, Oct. 26, 2023

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 17/152,394

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 16/151,653

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 15/348,716

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 13/984,559 Part 1 of 2

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 13/984,559 Part 2 of 2

Mar 11, 2025EXHIBITPATENT OWNER

PCT Request I.A. No. PCT/US2012/024591

Mar 11, 2025EXHIBITPATENT OWNER

Intl. Publication No. WO2012/109510 A1

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 17/170,275

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 18/436,836

Mar 11, 2025EXHIBITPATENT OWNER

MSN's Opening Invalidity Brief, Dec. 12, 2023

Mar 11, 2025EXHIBITPATENT OWNER

File History (Partial) for U.S.S.N. 16/706,323

Mar 11, 2025EXHIBITPATENT OWNER

Patent Owner's Update to Mandatory Notices

Jan 29, 2025PAPERPATENT OWNER

Supplemental Mandatory Notice Re: Related Matters

Jan 27, 2025PAPERPETITIONER

Notice: Notice filing date accorded

Dec 12, 2024PAPERBOARD

Notice : Mandatory Notice

Dec 6, 2024PAPERPATENT OWNER

Notice : Power of Attorney

Dec 6, 2024PAPERPATENT OWNER

U.S. Patent 11,298,349 ("the '349 patent")

Nov 18, 2024EXHIBITPETITIONER

U.S. Patent 9,717,720 ("Wilson")

Nov 18, 2024EXHIBITPETITIONER

WO 2010/083414 ("Brown")

Nov 18, 2024EXHIBITPETITIONER

Remington - The Science and Practice of Pharmacy (2005)

Nov 18, 2024EXHIBITPETITIONER

CABOMETYX Product Insert

Nov 18, 2024EXHIBITPETITIONER

COMETRIQ Product Insert

Nov 18, 2024EXHIBITPETITIONER

U.S. Patent 7,579,473 ("the '473 patent")

Nov 18, 2024EXHIBITPETITIONER

Gibson - Pharmaceutical Preformulation and Formulation (2009)

Nov 18, 2024EXHIBITPETITIONER

D.I. 168 Exelixis v. MSN, 22-cv-00228-RGA

Nov 18, 2024EXHIBITPETITIONER

D.I. 176 Exelixis v. MSN, 22-cv-00228-RGA

Nov 18, 2024EXHIBITPETITIONER

U.S. Application Serial No. 17/170,275 (Prosecution History Excerpt)

Nov 18, 2024EXHIBITPETITIONER

U.S. Provisional Application Serial No. 61/441,520 ("the '520 provisional")

Nov 18, 2024EXHIBITPETITIONER

U.S. Provisional Application Serial No. 61/441,527 ("the '527 provisional")

Nov 18, 2024EXHIBITPETITIONER

U.S. Application Serial No. 13/984,559 (Prosecution History Excerpt)

Nov 18, 2024EXHIBITPETITIONER

D.I. 175 Exelixis v. MSN, 22-cv-00228-RGA

Nov 18, 2024EXHIBITPETITIONER

D.I. 163 Exelixis v. MSN, 22-cv-00228-RGA

Nov 18, 2024EXHIBITPETITIONER

U.S. Application Serial No. 15/348,716 (Prosecution History Excerpt)

Nov 18, 2024EXHIBITPETITIONER

U.S. Application Serial No. 16/151,653 (Prosecution History Excerpt)

Nov 18, 2024EXHIBITPETITIONER

U.S. Application Serial No. 16/706,323 (Prosecution History Excerpt)

Nov 18, 2024EXHIBITPETITIONER

U.S. Application Serial No. 17/152,394 (Prosecution History Excerpt)

Nov 18, 2024EXHIBITPETITIONER

D.I. 162 Exelixis v. MSN, 22-cv-00228-RGA

Nov 18, 2024EXHIBITPETITIONER

Rowe et al. "Handbook of Pharmaceutical Excipients"

Nov 18, 2024EXHIBITPETITIONER

D.I. 186 Exelixis v. MSN, 22-cv-00228-RGA

Nov 18, 2024EXHIBITPETITIONER

U.S. Patent 7,169,789 ("Kubo")

Nov 18, 2024EXHIBITPETITIONER

Hoffmann "Elements of Synthesis Planning"

Nov 18, 2024EXHIBITPETITIONER

Newhouse et al. "The economies of synthesis"

Nov 18, 2024EXHIBITPETITIONER

Burns et al. "Redox Economy in Organic Synthesis"

Nov 18, 2024EXHIBITPETITIONER

Pross et al.

Nov 18, 2024EXHIBITPETITIONER

Furuta et al.

Nov 18, 2024EXHIBITPETITIONER

Aulton "Dosage Form Design and Manufacture"

Nov 18, 2024EXHIBITPETITIONER

Felpin et al.

Nov 18, 2024EXHIBITPETITIONER

U.S. EPA - Toxicological Review of Quinoline (2001)

Nov 18, 2024EXHIBITPETITIONER

FDA - Guidance for Industry, Genotoxic and Carcinogenic Impurities (2008)

Nov 18, 2024EXHIBITPETITIONER

EMEA - Guideline on the Limits of Genotoxic Impurities (2006)

Nov 18, 2024EXHIBITPETITIONER

Notice : Power of Attorney

Nov 18, 2024PAPERPETITIONER

Petition : as filed

Nov 18, 2024PAPERPETITIONER

Declaration of Graham Buckton, Ph.D.

Nov 18, 2024EXHIBITPETITIONER

Declaration of William Dichtel, Ph.D.

Nov 18, 2024EXHIBITPETITIONER